Nerviano Medical Sciences Announces FDA Clearance of Investigational New Drug (IND) for NMS-03592088 in positive r/r AML

Nerviano Medical Sciences Announces FDA Clearance of Investigational New Drug (IND) for NMS-03592088 ((NMS-088), a novel, potent FLT3 inhibitor) in positive Relapsed or Refractory Acute Myeloid Leukemia.

full article